NCT00398151View on ClinicalTrials.gov

To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 1, 2005

Primary Completion Date

January 18, 2006

Study Completion Date

January 18, 2006

Conditions
Asthma
Interventions
DRUG

MK0476, montelukast sodium / Duration of Treatment: 12 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00398151 - To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366) | Biotech Hunter | Biotech Hunter